← Eichor
Study identifier: NCT07345481 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Stimulus Equivalence Learning in Acquired Brain Injury.

Condition: Acquired Brain Injury (Including Stroke)  ·  Sponsor: Klimmendaal Revalidatiespecialisten

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

Stimulus Equivalence Learning (SEL) is a form of learning in which stimuli (such as words, pictures, or sounds) become linked to one another in memory, even though this specific connection has not been directly taught. In a typical SEL task, two relations are taught explicitly (A→B and A→C), and the untrained relation (B→C) is then tested. This indirect relation is not intentionally or consciously learned and is considered a form of implicit learning. The principle of stimulus equivalence learning is still rarely applied in cognitive rehabilitation after acquired brain injury (ABI), with the exception of a few small (N=1) treatment studies that have shown positive effects. However, it remains unclear to what extent ABI may affect the ability to acquire stimulus equivalence.

This description comes directly from the study's public registry record.

Talk to the study team

Edo Grevers, MSc.  ·  +31620839323  ·  e.grevers@klimmendaal.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Klimmendaal RevalidatiespecialistenArnhem, Gelderland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07345481